Immuno Oncology Assays Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

[Tejas More]

Immuno Oncology Assays Market to value over US $ 6 Billion and register a CAGR of over 12% during the forecast period from 2019 to 2026.
Rising exposure to carcinogenic agents and a subsequent rise in the number of cancer cases and casualties is surging the demand for effective treatment will further boost industry growth during the forecast timeline. Continuous research for novel cancer treatment is projected to foster immuno oncology assays market growth. The significant factors contributing to the growth of the global immuno oncology assays market are increasing incidences of cancer and rising adoption of targeted therapy over traditional therapy. However, unfavourable regulatory and reimbursement scenario and high capital investment amount might hinder the overall market at a global level.
Based on indication, the immuno-oncology assays market is segmented into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment is projected to be the fastest-growing segment during the forecast period, as major firms are focusing on immuno-oncology research for lung cancer owing to its increasing incidence.
Based on products, the immuno-oncology assays market is segmented into consumables and software. The consumables segment garnered the major immuno oncology assays market share and is also expected to register the highest CAGR during the forecast period. The availability of variety, increasing use of reagents in various oncology therapeutic treatments, continuous research on cancer immunotherapy is fueling the growth of this segment.
Based on application, the immuno-oncology assays market is segmented into research applications and clinical diagnostics. Research applications held significant market share and are projected to grow with a robust CAGR value during the forecast period. The increasing significance of biomarker-based drug development and clinical trials and the awareness of cancer immunotherapy are the principal factors driving immuno oncology assays market growth.
According to the region, North America held major revenue in the global immuno oncology assays market. This is accredited to the increasing cancer cases, the advanced healthcare infrastructure, and rising adoption of targeted therapy. Continued research with the favourable scenario for capital funding also boosts the immuno oncology assays market growth.
The Asia Pacific immuno oncology assays market will thrive at the highest CAGR in the projected time frame owing to the rising geriatric population, increasing cancer cases, and augmenting health awareness.
Prominent Players operating in the global immuno-oncology assays industry are Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US).
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3364&...
Competitive Landscape
● Thermo Fisher entered into a deal with Invivoscribe Technologies to develop NGS-based in-vitro diagnostic oncology tests in order to strengthen their position in the global market
● Illumina launched its TruSight Oncology 500 assay, which is used to identify known and emerging tumour biomarkers, this expanded the product portfolio and explored the potential of the market
Immuno Oncology Assays Market Segmentation
By Product
● Consumables
● Software
By Technology
● PCR
● Immunoassay
● Ngs
● Flow Cytometry
● Other Technologies
By Indication
● Lung Cancer
● Colorectal Cancer
● Melanoma
● Bladder Cancer
● Other Cancers
By Application
● Research Applications
● Clinical Diagnostics
By Region
● Europe
● North America
● APAC
● Latin America
● Rest of World
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3364&...

Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
FutureWise Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on the global immuno oncology assays market by product, by technology, by indication by application, and by region
● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and the overall market
● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world
● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Primary Data
2.1.1 Key Data From Primary Sources
2.1.2 Key Industry Insights
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.4.1 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Immuno-Oncology Assays: Market Overview
4.2 North America: Immuno-Oncology Assays Market, By Product and Country (2018)
4.3 Immuno-Oncology Assays Market, By Application (2018 vs 2026)
4.4 Immuno-Oncology Assays Market, By Technology (2018 vs 2026)
4.5 Geographical Snapshot of the Immuno-Oncology Assays Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Cancer and Increasing Adoption of Targeted Therapy
5.2.2 Restraints
5.2.2.1 Unfavorable Regulatory and Reimbursement Scenario
5.2.2.2 High Amount of Capital Investments and Low Benefit-Cost Ratio
5.2.3 Opportunities
5.2.3.1 Companion Diagnostics

6 Immuno-Oncology Assays Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Consumables Segment Will Continue to Dominate the Immuno-Oncology Assays Market During the Forecast Period
6.3 Software
6.3.1 The Need to Deliver Accurate and Timely Analysis of Diagnostic Tests has Resulted in the Increased Adoption of Software

7 Immuno-Oncology Assays Market, By Technology
7.1 Introduction
7.2 PCR
7.2.1 Emergence of Advanced PCR Technologies to Support Market Growth
7.3 Immunoassay
7.3.1 Immunoassays Have the Potential to Reduce Cancer Mortality Rate By Facilitating the Diagnosis of Cancer in the Early Stage
7.4 Ngs
7.4.1 Ngs Segment to Register the Highest Growth Rate During the Forecast Period
7.5 Flow Cytometry
7.5.1 Flow Cytometry Plays A Critical Role in Clinical Research Studies
7.6 Other Technologies

8 Immuno-Oncology Assays Market, By Indication
8.1 Introduction
8.2 Lung Cancer
8.2.1 Increasing R&D Activities on Lung Immuno-Oncology Assays is A Key Market Driver
8.3 Colorectal Cancer
8.3.1 High Success Rate of Immuno-Oncology Assays in Crc Treatment Decisions to Drive Market Growth
8.4 Melanoma
8.4.1 Growing Cases of Melanoma to Drive Market Growth
8.5 Bladder Cancer
8.5.1 Bladder Cancer Segment to Witness Slower Growth Owing to the Limited Adoption of Immuno-Oncology Assays
8.6 Other Cancers

9 Immuno-Oncology Assays Market, By Application
9.1 Introduction
9.2 Research Applications
9.2.1 Rising Prominence of Biomarker-Based Drug Development and Clinical Trials to Drive the Research Applications Market
9.3 Clinical Diagnostics
9.3.1 Benefits of Immuno-Oncology Assays are Driving Its Adoption in Clinical Diagnostics
10 Immuno-Oncology Assays Market, By Region (Page No. - 56)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Increasing Demand for Immunotherapy Medicine Forms A Key Driver of Market Growth in the US
10.2.2 Canada
10.2.2.1 High Burden of Cancer to Drive the Demand for Immuno-Oncology Assays
10.3 Europe
10.3.1 Rising Focus on Biomarker Development in Several Eu Countries to Support Market Growth
10.4 Asia Pacific
10.4.1 Increasing Demand for Better Healthcare Services in Developing Economies Will Contribute to Market Growth
10.5 Rest of the World

11 Competitive Landscape
11.1 Overview
11.2 Vendor Benchmarking
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Market Ranking Analysis, 2017
11.5 Competitive Situation and Trends
11.5.1 Collaborations
11.5.2 Product Launches
11.5.3 Acquisitions
11.5.4 Expansions

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise View)*
12.1 Thermo Fisher Scientific, Inc.
12.2 Roche Diagnostics
12.3 Agilent Technologies, Inc.
12.4 Illumina, Inc.
12.5 Nanostring Technologies, Inc.
12.6 Sartorius AG
12.7 Foundation Medicine
12.8 HTG Molecular Diagnostics, Inc.
12.9 Qiagen
12.10 Merck
12.11 Perkinelmer
Inquire further details about this report at: [e-mail]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [e-mail]
Phone: [phone]
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com